{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:20:26Z","timestamp":1778750426415,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","award":["Caroline Wiess Law Fund for Research in Molecular Medicine"],"award-info":[{"award-number":["Caroline Wiess Law Fund for Research in Molecular Medicine"]}],"id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL039693"],"award-info":[{"award-number":["HL039693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL135793"],"award-info":[{"award-number":["HL135793"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL150784"],"award-info":[{"award-number":["HL150784"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL125774"],"award-info":[{"award-number":["HL125774"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1111\/jth.15460","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T15:06:18Z","timestamp":1626188778000},"page":"2702-2709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phage display broadly identifies inhibitor\u2010reactive regions in von Willebrand factor"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-6322","authenticated-orcid":false,"given":"Andrew","family":"Yee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manhong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6112-6166","authenticated-orcid":false,"given":"Stacy E.","family":"Croteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan A.","family":"Shavit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-2089","authenticated-orcid":false,"given":"Steven W.","family":"Pipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Siemieniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ginsburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15460_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2013-11-540534","article-title":"A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice","volume":"124","author":"Yee","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.15460_bb0015","first-page":"17","article-title":"Von Willebrand factor: form for function","volume":"40","author":"Yee","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.15460_bb0020","series-title":"Williams hematology","article-title":"VON Willebrand disease","author":"Johnsen","year":"2021"},{"key":"10.1111\/jth.15460_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15460_bb0030","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.15460_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/bjh.13395","article-title":"First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease","volume":"171","author":"Baaij","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15460_bb0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0140-6736(92)90874-3","article-title":"Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs","volume":"339","author":"Ehrenforth","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/jth.15460_bb0045","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","article-title":"A randomized trial of factor VIII and neutralizing antibodies in hemophilia A","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15460_bb0050","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.15460_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood.V72.1.116.116","article-title":"Further specificity characterization of von Willebrand factor inhibitors developed in two patients with severe von Willebrand disease","volume":"72","author":"Lopez\u2010Fernandez","year":"1988","journal-title":"Blood"},{"key":"10.1111\/jth.15460_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1055\/s-0037-1614572","article-title":"Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino\u2010terminal region flanking the A1 domain","volume":"81","author":"Shibata","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15460_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0037-1613799","article-title":"Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease","volume":"83","author":"Tout","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15460_bb0070","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1055\/s-0038-1656047","article-title":"Autoantibody selectively inhibits binding of von Willebrand factor to glycoprotein ib. Recognition site is located in the A1 loop of von Willebrand factor","volume":"77","author":"Mohri","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15460_bb0075","doi-asserted-by":"crossref","first-page":"14428","DOI":"10.1002\/anie.201908308","article-title":"Phage display: simple evolution in a petri dish (Nobel Lecture)","volume":"58","author":"Smith","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1111\/jth.15460_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI114169","article-title":"A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide","volume":"84","author":"Bahou","year":"1989","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1111\/jth.15460_bb0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.thromres.2007.05.015","article-title":"What a polyclonal antibody sees in von Willebrand factor","volume":"121","author":"Tan","year":"2008","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15460_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-1759(99)00012-5","article-title":"Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients","volume":"224","author":"Kuwabara","year":"1999","journal-title":"J Immunol Methods"},{"key":"10.1111\/jth.15460_bb0095","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1046\/j.1365-2141.2001.02839.x","article-title":"Epitope mapping of factor VIII inhibitor antibodies of Chinese origin","volume":"113","author":"Huang","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1111\/jth.15460_bb0100","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.jmb.2014.09.020","article-title":"Precise and efficient antibody epitope determination through library design, yeast display and next\u2010generation sequencing","volume":"427","author":"Van Blarcom","year":"2015","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1111\/jth.15460_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01495-20","article-title":"High\u2010resolution mapping of human norovirus antigens via genomic phage display library selections and deep sequencing","volume":"95","author":"Huang","year":"2020","journal-title":"J Virol"},{"issue":"30","key":"10.1111\/jth.15460_bb0110","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1073\/pnas.1511328112","article-title":"Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13","volume":"112","author":"Kretz","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15460_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073518","article-title":"Functional display of platelet\u2010binding VWF fragments on filamentous bacteriophage","volume":"8","author":"Yee","year":"2013","journal-title":"PLoS One"},{"key":"10.1111\/jth.15460_bb0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage\u2010specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"issue":"Suppl 4","key":"10.1111\/jth.15460_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/hae.13475","article-title":"Fifth Aland Island conference on von Willebrand disease","volume":"24","author":"Berntorp","year":"2018","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15460_bb0130","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1182\/bloodadvances.2019000656","article-title":"Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies","volume":"3","author":"Weyand","year":"2019","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15460_bb0135","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1111\/jth.15460_bb0140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA\u2010seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1111\/jth.15460_bb0145","unstructured":"Dako. Polyclonal rabbit anti\u2010human von Willebrand factor code A0082. https:\/\/www.agilent.com\/cs\/library\/packageinsert\/public\/SSA0082IVD\u2010US_01.pdf. Accessed December 29, 2020."},{"key":"10.1111\/jth.15460_bb0150","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1538-7836.2011.04250.x","article-title":"Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population","volume":"9","author":"Mohl","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15460_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MBC.0000000000000865","article-title":"von Willebrand factor alloantibodies in type 3 von Willebrand disease","volume":"31","author":"Faganel Kotnik","year":"2020","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15460","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15460","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622004652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622004652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:29:48Z","timestamp":1761535788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622004652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1538783622004652"],"URL":"https:\/\/doi.org\/10.1111\/jth.15460","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.08.434464","asserted-by":"object"}]},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phage display broadly identifies inhibitor\u2010reactive regions in von Willebrand factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}